Prophylactic Treatment With Oseltamivir
NCT03899571
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
222
Enrollment
OTHER
Sponsor class
Conditions
Influenza, Human
Interventions
DRUG:
Oseltamivir Oral Capsule for 5 days post-exposure
DRUG:
Oseltamivir Oral Capsule for 10 days post-exposure
Sponsor
University Medical Centre Ljubljana